Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
about
EGFR/HER-targeted therapeutics in ovarian cancerGenetic and teratogenic approaches to craniofacial developmentEpidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence.Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progressionEpidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagenLessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer.ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution.Id-I stimulates cell proliferation through activation of EGFR in ovarian cancer cellsPEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.Activated epidermal growth factor receptor in ovarian cancer.EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.Trigger release liposome systems: local and remote controlled delivery?The complex function of hsp70 in metastatic cancer.Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin.An in vitro and in vivo investigation of the antimetastatic effects of a Chinese medicinal decoction, erxian decoction, on human ovarian cancer models.Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways.Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.Functional interplay between type I collagen and cell surface matrix metalloproteinase activity.Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer.Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
P2860
Q26863231-01149DED-633E-44D7-85C8-FF00A01E1371Q28140486-9A8F38C8-BD0C-4037-B89D-E9E10AC3CFE1Q30483791-5F4AFC6C-0C0F-4AE1-972C-9B1648530330Q33719284-74B059EF-3E6E-4625-912B-7C9C2DB52748Q33744931-C953A0B0-8578-4FD3-8815-BB1BC980194EQ34332205-E42832C0-CF4E-440C-B43C-79035698BB31Q34364547-5CF3E7B4-29FC-4A03-B5A6-07F1E325C041Q35098085-11FA9183-59DC-477A-9B83-CAC65AC41177Q36068428-BF9B318F-FD35-4065-9A5C-585C52EBD11BQ36323418-D4BAF383-C2C9-416F-AA59-DB5E1A3AB281Q36695270-2F4A4572-5937-4615-8F28-992FEF9F1EFFQ36752013-F12C45D4-3B98-4588-ABD5-F8F88B7C6BFCQ36752057-904A60D0-1CB1-4360-8248-37CC15F5EFEAQ36981918-0F4978B2-32F9-4E5B-8119-20E95C1089C9Q37260078-F28D22DC-E7E4-488D-8573-67492F74822EQ37353288-18B5CA00-4FB2-4B2F-92C5-215AB2373886Q37399283-2114F08E-C801-45F0-8FA4-E63030DA444DQ37972351-EA258178-2C30-4740-B078-68712BF72E40Q38173257-0E87575B-B360-4695-9F41-D0C08B2E176BQ38355136-218DFE70-4550-466A-A604-87F556156FC1Q39503156-EAB27334-3846-4A7C-8743-E300BA489B49Q40309916-2D347461-A8AE-4AB0-8D34-B27A9E3C0616Q40543731-A7C9D4EE-3DE2-4430-8F84-9C4FEB110212Q40809094-7A55FC42-DAE4-43EF-AF59-F1D9B54DEAA4Q40957075-6BB75C56-7996-449F-A361-4407F44255F7Q43741320-5D91C708-EE57-439C-A065-FCB294FFEA65Q49375848-B120DD1D-F3AD-4838-A63B-84B48632F9F1
P2860
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@ast
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@en
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@nl
type
label
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@ast
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@en
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@nl
prefLabel
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@ast
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@en
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@nl
P2093
P2860
P1476
Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
@en
P2093
L G Hudson
S M Ellerbroek
P2860
P356
10.1002/(SICI)1097-0215(19981029)78:3<331::AID-IJC13>3.0.CO;2-9
P407
P577
1998-10-29T00:00:00Z